The go-to metaphor for cancer drugs known as immune checkpoint inhibitors is a brake-release lever…
eabramovichAugust 28, 2020
Joining Forces: Harvard University, AbbVie Form Research Alliance to Address Emergent Viral Diseases
Harvard University and AbbVie today announced a $30 million collaborative research alliance, launching a multi-pronged…
A new bioluminescent reporter that tracks DNA double stranded break (DSB) repair in cells has…
eabramovichAugust 27, 2020
Xu Yu, MD, Ragon Institute group leader, recently published a study entitled “Distinct viral reservoirs in individuals…
eabramovichAugust 27, 2020
Scientists at the Broad Institute of MIT and Harvard and Massachusetts General Hospital have revealed…
eabramovichAugust 27, 2020
Decreasing discovery rates and increasing resistance have underscored the need for novel therapeutic options to…
eabramovichAugust 26, 2020
Infections that reach the placenta can lead to spontaneous abortions, intrauterine growth restriction, congenital abnormalities,…
eabramovichAugust 26, 2020
These days, novel diseases such as COVID-19 are pushing scientists to work real hard and…
eabramovichAugust 26, 2020
We work as research associates in the lab of Pardis Sabeti, which studies the genetics of…
eabramovichAugust 26, 2020
A new study by researchers at MassBiologics of UMass Medical School published in Nature Communications suggests that COVID…
eabramovichAugust 25, 2020
